Principal Financial Group
CRDF icon

Principal Financial Group’s Cardiff Oncology CRDF Stock Holding History

Principal Financial Group’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-54,691
Closed -$136K – 2531
2022
Q1 		$136K Sell
54,691
-25,616
-32% -$90.6K ﹤0.01% 2399
2021
Q4 		$483K Sell
80,307
-67,034
-45% -$400K ﹤0.01% 2132
2021
Q3 		$981K Sell
147,341
-2,231
-1% -$14K ﹤0.01% 2008
2021
Q2 		$995K Buy
+149,572
New +$1.27M ﹤0.01% 2042

Other funds holding CRDF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Principal Financial Group's CRDF Position: Q2 2022 in Review

Principal Financial Group sold out of Cardiff Oncology (CRDF) in Q2 2022, closing a stake of 54,691 shares — an estimated $136K sold.

Principal Financial Group first reported a position in CRDF in Q2 2021 and held it in 4 quarters. The position peaked at $995K in Q2 2021. 67 funds tracked by Wall St. Rank hold CRDF as of Q2 2022.

  • Principal Financial Group reported no remaining Cardiff Oncology position as of Q2 2022 after selling out during the quarter.
  • Principal Financial Group sold 54,691 Cardiff Oncology shares in Q2 2022, an estimated $136K.
  • Principal Financial Group first reported a position in Cardiff Oncology in Q2 2021 and held it in 4 quarters.
  • Principal Financial Group's Cardiff Oncology position peaked at $995K in Q2 2021.
  • 67 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2022.

Based on Principal Financial Group's 13F filing for Q2 2022, filed 10 Aug 2022.